Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH

NCT02003742 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
104
Enrollment
INDUSTRY
Sponsor class

Stopped The study was stopped because in two other clinical studies the drug was not superior in comparison with placebo

Conditions

Interventions

Sponsor

RECORDATI GROUP